Actio Biosciences raised $66M in Series B funding to enhance drug research targeting rare genetic diseases. The round was led by Regeneron Ventures and Deerfield Management.
Amount Raised
$66 Million
Round Type
Series B
San DiegoBiotechnologyHealth CareTherapeuticsInvestors
Description
Actio Biosciences, a San Diego-based biotechnology startup, announced Wednesday it raised a $66 million Series B financing to support drug research. The company is initially focusing on rare genetic diseases, with broader potential. Actio's advanced program targets Charcot-Marie-Tooth disease and a second program for genetic epilepsy is expected to enter clinical testing soon. The funding round was co-led by Regeneron Ventures and Deerfield Management, with participation from Canaan, Droia Ventures, and Euclidean Capital.
Quick answer
Actio Biosciences raised $66 Million in a Series B round, dated June 18, 2025. Investors: Canaan, Droia Ventures, Euclidean Capital, Regeneron Ventures and Deerfield Management. Actio Biosciences is based in San Diego, California, United States.
- How much did Actio Biosciences raise?
- Actio Biosciences raised $66 Million in a Series B round on June 18, 2025.
- Who invested in Actio Biosciences?
- Canaan, Droia Ventures, Euclidean Capital, Regeneron Ventures and Deerfield Management are named as investors in this round.
- What does Actio Biosciences do?
- Actio Biosciences is a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases.
- Where is Actio Biosciences based and how big is it?
- Actio Biosciences is based in San Diego, California, United States. Fundz records about 41 employees.
- Who are the decision-makers at Actio Biosciences?
- Fundz holds 1 contact at Actio Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Actio Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Faeth Therapeutics raised $24M on August 1, 2025.
- Silexion Therapeutics raised $3.6M on August 1, 2025.
- ForCast Orthopedics raised $3.8M (Seed) on August 1, 2025.
- FibroBiologics raised $5M (Funding Round) on July 31, 2025.
- Bariks Health raised $7M on July 30, 2025.
- Spliceor raised an undisclosed amount (Seed) on July 29, 2025.
Who to call at Actio Biosciences, and when
A new round usually means Actio Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Actio Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Actio Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Actio Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Actio Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansActio Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.